MedTrace Logo

A Study to Evaluate the Efficacy of a Postbiotic Supplement on Menopausal Symptoms in Premenopausal Women

NCT07570043 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-06

No results posted yet for this study

Summary

The goal of this consumer study is to evaluate the efficacy of a postbiotic supplement on menopausal symptoms and hormonal balance in premenopausal women ages 35-55 (inclusive) who are generally healthy. The main question it aims to answer is:

Will the postbiotic supplement improve menopausal symptoms in premenopausal women?

If there is a comparison group: Researchers will compare placebo and active supplement to see if there is a statistically significant difference in effect.

Participants will take the supplement/placebo daily for 8 weeks and complete questionnaires on a regular basis.

Conditions

  • Premenopause

Interventions

DIETARY_SUPPLEMENT

Supplement

Active supplement

OTHER

Placebo

Inactive supplement

Sponsors & Collaborators

  • Able Biolabs, LLC

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-04
Primary Completion
2026-05-15
Completion
2026-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07570043 on ClinicalTrials.gov